Drug intelligence / Profile preview

strychnine

Development stage
Unknown
Modality
Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral, Inhalation, Intravenous, Intramuscular, Subcutaneous
01

Overview

Strychnine is a highly toxic, colorless, bitter, crystalline alkaloid primarily used as a pesticide for killing small vertebrates such as birds and rodents. It was historically used in medicine as a cardiac, respiratory, and digestive stimulant but is no longer employed for therapeutic purposes due to its toxicity. Strychnine acts as a potent neurotoxin by competitively antagonizing glycine receptors in the spinal cord and brainstem. This inhibition of glycine-mediated neurotransmission removes the normal inhibitory control over motor neurons, resulting in severe muscle spasms and convulsions that can lead to death by respiratory failure or exhaustion. Strychnine poisoning can occur through ingestion, inhalation, or injection; only small amounts are needed to cause serious effects or death[1][2][4][6][8].

02

Targets

Glycine receptorNicotinic Acetylcholine Receptor

Beyond the preview

Go deeper on strychnine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on strychnine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call